ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,219Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 1111

$966K Total Retail Price of All Prescriptions

Rank: 44 out of 1111

757 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 757 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 16,205 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 1,235 882 1 2
AMLODIPINE BESYLATE 1,209 953 2 7
SIMVASTATIN 1,100 789 3 5
METFORMIN HCL 770 563 4 8
PRAVASTATIN SODIUM 698 517 5 17
HYDROCODONE-ACETAMINOPHEN 642 424 S3 6 1
OMEPRAZOLE 633 458 7 4
MELOXICAM 448 357 8 18
LEVOTHYROXINE SODIUM 436 337 9 3
GLIMEPIRIDE 435 317 10 61
GABAPENTIN 417 331 11 10
CARVEDILOL 404 327 12 21
HYDROCHLOROTHIAZIDE 379 267 13 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 362 239 14 23
FUROSEMIDE 358 230 15 6
LOSARTAN POTASSIUM 339 282 16 34
FLUTICASONE PROPIONATE 330 234 17 27
METOPROLOL TARTRATE 296 192 18 12
TAMSULOSIN HCL 293 278 19 28
TRAMADOL HCL 290 277 20 13
EVISTA 286 286 21 148
POTASSIUM CHLORIDE 268 183 22 9
AMOXICILLIN 253 148 23 131
JANUVIA 248 218 24 75
ZOLPIDEM TARTRATE 241 137 25 16
CLONIDINE HCL 238 147 26 42
PROAIR HFA 222 120 27 38
CRESTOR 217 165 28 33
NEXIUM 208 118 29 26
LOSARTAN-HYDROCHLOROTHIAZIDE 190 150 30 72
ATORVASTATIN CALCIUM 190 141 30 15
AZITHROMYCIN 189 116 32 39
RANITIDINE HCL 187 130 33 29
SERTRALINE HCL 185 112 34 24
ACTOS 175 162 35 98
SPIRIVA 167 100 36 53
CITALOPRAM HBR 160 102 37 14
ALENDRONATE SODIUM 157 126 38 35
ETODOLAC 155 87 39 137
CYCLOBENZAPRINE HCL 148 52 R 40 37
FINASTERIDE 147 132 41 115
CLOPIDOGREL 144 110 42 30
DOXYCYCLINE HYCLATE 141 100 43 113
GLIPIZIDE ER 140 104 44 99
CEPHALEXIN 137 92 45 89
TRIAMCINOLONE ACETONIDE 134 102 46 128
CIPROFLOXACIN HCL 108 88 47 58
BUSPIRONE HCL 102 80 48 96
DOXAZOSIN MESYLATE 100 93 49 87
DONEPEZIL HCL 100 97 49 25
LIPITOR 99 71 51 116
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 51 52 71
JANUMET 94 76 52 174
PIOGLITAZONE HCL 91 80 R 54 269
SYMBICORT 91 71 54 176
LANTUS 89 61 56 46
DIOVAN HCT 88 69 57 94
METFORMIN HCL ER 87 83 58 84
PLAVIX 86 68 59 49
ADVAIR DISKUS 84 47 60 43
NAMENDA 82 79 61 31
FLUOXETINE HCL 81 52 62 44
MEGESTROL ACETATE 80 68 R 63 103
GLIPIZIDE 76 46 64 57
VENTOLIN HFA 73 15 65 122
DIGOXIN 70 56 66 47
DIOVAN 70 57 66 51
MECLIZINE HCL 69 60 68 162
LEVOFLOXACIN 68 50 69 88
NAPROXEN 68 31 69 85
INSULIN SYRINGE 67 51 71 167
WARFARIN SODIUM 66 41 72 19
ISOSORBIDE MONONITRATE ER 66 34 72 73
BENAZEPRIL HCL 66 54 72 97
GLYBURIDE 66 56 R 72 59
PROMETHAZINE HCL 65 21 R 76 69
ATENOLOL 64 48 77 22
DETROL LA 64 59 77 139
PANTOPRAZOLE SODIUM 63 32 79 50
ESTRADIOL 62 38 R 80 102
METOPROLOL SUCCINATE 56 52 81 20
ZETIA 56 48 81 109
FLUOCINONIDE 52 36 83 413
KETOCONAZOLE 50 33 84 314
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.